Figures cited by The Punch from the Manufacturers Association of Nigeria (MAN) show that the escalating tensions in the Middle East are beginning to impact Nigeria’s pharmaceutical sector. Export earnings are at risk as shipping routes become more dangerous and logistics costs skyrocket, particularly for companies sourcing active ingredients from that region.
MAN warned that if the conflict enters its second month without resolution, Nigerian manufacturers may face a severe shortage of raw materials. This could lead to a spike in the price of essential drugs locally, as the cost of insurance and freight for alternative routes is significantly higher.
The Guardian noted that “manufacturers are seeking government buffers against global shocks,” and Vanguard reported that “pharmaceutical supply chains are under unprecedented pressure.”
Echotitbits take: This is a reminder of how interconnected our local health is with global politics. If the pharma sector takes a hit, it’s not just an “economy” story—it’s a “public health” story. Watch for the Ministry of Health to potentially ease import duties on raw materials to compensate.
Source: The Punch – https://punchng.com/middle-east-tensions-threaten-pharma-export-earnings-man/, and March 28, 2026
Photo credit: The Punch
